The signal pathways and treatment of cytokine storm in COVID-19

L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis
and is more devastating than any other previous infectious disease. It has affected a …

Colchicine—update on mechanisms of action and therapeutic uses

YY Leung, LLY Hui, VB Kraus - Seminars in arthritis and rheumatism, 2015 - Elsevier
Objectives To review the literature and provide an update on the mechanisms of action and
therapeutic uses of oral colchicine in arthritis and inflammatory conditions. Methods We …

Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the …

SG Deftereos, G Giannopoulos, DA Vrachatis… - JAMA network …, 2020 - jamanetwork.com
Importance Severe acute respiratory syndrome coronavirus 2 infection has evolved into a
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …

The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation

GJ Martinez, DS Celermajer, S Patel - Atherosclerosis, 2018 - Elsevier
Atherosclerosis is considered a chronic inflammatory disease of the arterial wall. Recently,
compelling evidence has arisen for the role of monocytes and neutrophils and a particular …

P2X7 receptor and the NLRP3 inflammasome: Partners in crime

P Pelegrin - Biochemical pharmacology, 2021 - Elsevier
Adenosine triphosphate (ATP) is a molecule that on one hand plays a central role in cellular
energetics and which on the other is a ubiquitous signaling molecule when released into the …

[HTML][HTML] The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

SG Deftereos, G Siasos, G Giannopoulos… - Hellenic journal of …, 2020 - Elsevier
Objective Colchicine has been utilized safely in a variety of cardiovascular clinical
conditions. Among its potential mechanisms of action is the non-selective inhibition of …

The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease

R Bartlett, L Stokes, R Sluyter, DR Sibley - Pharmacological reviews, 2014 - Elsevier
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …

P2X7 receptor: an emerging target in central nervous system diseases

B Sperlágh, P Illes - Trends in pharmacological sciences, 2014 - cell.com
The ATP-sensitive homomeric P2X7 receptor (P2X7R) has received particular attention as a
potential drug target because of its widespread involvement in inflammatory diseases as a …

Colchicine: an ancient drug with novel applications

B Dasgeb, D Kornreich, K McGuinn… - British Journal of …, 2018 - academic.oup.com
Colchicine is a treatment for gout that has been used for more than a millennium. It is the
treatment of choice for familial Mediterranean fever and its associated complication …

Inflammation-induced thrombosis: mechanisms, disease associations and management

K Aksu, A Donmez, G Keser - Current pharmaceutical design, 2012 - ingentaconnect.com
Although inflammation-induced thrombosis is a well-known entity, its pathogenesis remains
complicated. There are complex interactions between inflammation and hemostasis …